Source link : https://www.newshealth.biz/health-news/new-pcsk9s-nearing-market-will-help-meet-cholesterol-targets/
The market for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors to lower cholesterol is taking off with several new drugs being introduced or nearing the market, which will increase competition and enable more patients to reach low-density lipoprotein (LDL) goals, experts said. One new anti-PCSK9 agent — lerodalcibep from LIB Therapeutics — is a small […]
Author : News Health
Publish date : 2024-07-24 09:50:01
Copyright for syndicated content belongs to the linked Source.
Categories